CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | Gordon Stephen Chief Financial Officer | Sale 10b5-1 | −15,000 | $85.45 | $1.3M | 13,075 |
| 2024-02-01 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −8,833 | 28,167 | ||
| 2024-02-01 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −3,644 | 2,084 | ||
| 2024-02-01 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −2,523 | 67,477 | ||
| 2024-01-23 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion 10b5-1 | +2,330 | $16.00 | $37K | 16,705 |
| 2024-01-23 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −2,330 | $90.09 | $210K | 14,375 |
| 2024-01-23 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −2,330 | 5,706 | ||
| 2024-01-16 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion 10b5-1 | +10,000 | $13.28 | $133K | 24,375 |
| 2024-01-16 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −9,867 | $80.40 | $793K | 14,508 |
| 2024-01-16 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −133 | $81.06 | $11K | 14,375 |
| 2024-01-16 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −10,000 | 42,000 | ||
| 2024-01-02 | Gordon Stephen Chief Financial Officer | Exercise or conversion 10b5-1 | +15,000 | $13.28 | $199K | 28,075 |
| 2024-01-02 | Gordon Stephen Chief Financial Officer | Sale 10b5-1 | −15,000 | $77.07 | $1.2M | 13,075 |
| 2024-01-02 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −15,000 | 37,000 | ||
| 2023-12-15 | Provost Miriam VP, Global Regulatory Affairs | Gift | −1,785 | 23,348 | ||
| 2023-12-13 | Provost Miriam VP, Global Regulatory Affairs | Exercise or conversion | +415 | $16.14 | $7K | 24,026 |
| 2023-12-13 | Provost Miriam VP, Global Regulatory Affairs | Sale | −206 | $75.10 | $15K | 23,820 |
| 2023-12-13 | Provost Miriam VP, Global Regulatory Affairs | Exercise or conversion | +1,632 | $66.10 | $108K | 25,452 |
| 2023-12-13 | Provost Miriam VP, Global Regulatory Affairs | Sale | −1,509 | $75.10 | $113K | 23,943 |
| 2023-12-13 | Provost Miriam VP, Global Regulatory Affairs | Exercise or conversion | +3,597 | $38.46 | $138K | 27,540 |
Page 22 of 38 · 744 trades